CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 

Cumulative Vir Biotechnology Inc 's Quick Ratio for Trailing Twelve Months Period

VIR's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

VIR Quick Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Current Liabilities Growth 31.87 % 227.25 % 94.51 % 244.47 % 203.55 %
Y / Y Cash & cash equivalent Growth 201.04 % 160.78 % 65.39 % -22.99 % -7.15 %
Quick Ratio for Trailing Twelve Months Period 3.45 2.71 2.4 2.7 3.69
Total Ranking # 843 # 1290 # 1438 # 1420 # 876
Seq. Current Liabilities Growth -35.5 % -31.96 % 105.82 % 46 % 60.06 %
Seq. Cash & cash equivalent Growth 7.56 % 77.11 % 113.84 % -26.1 % -6.83 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Vir Biotechnology Inc Cash & cash equivalent average more than doubled by 201.04 % in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Vir Biotechnology Inc 's Quick Ratio for Trailing Twelve Months Period to 3.45, Quick Ratio for Trailing Twelve Months Period remained below Vir Biotechnology Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 136 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Vir Biotechnology Inc . While Quick Ratio for Trailing Twelve Months Period overall ranking has improved so far to 843, from total ranking in previous quarter at 1290.

What is Quick Ratio?
Learn more about VIR
Quick Ratio VIR in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 137
Sector # 507
S&P 500 # 842


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
8.73 5.11 2.4
(Dec 31 2020)   (Mar 31 2022)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Homology Medicines Inc  9.40 
Bionano Genomics Inc   9.39 
Invivyd Inc   9.39 
Fennec Pharmaceuticals Inc   9.35 
Revolution Medicines Inc   9.24 
Allovir Inc   9.21 
Avrobio Inc   8.98 
Finch Therapeutics Group Inc   8.98 
Seqll Inc   8.96 
Surrozen Inc   8.85 
Checkmate Pharmaceuticals Inc   8.83 
Microbot Medical Inc   8.73 
Voyager Therapeutics Inc   8.64 
Arcellx Inc   8.58 
Tcr2 Therapeutics Inc   8.55 
Tscan Therapeutics Inc   8.52 
Aptose Biosciences Inc   8.49 
Black Diamond Therapeutics Inc   8.25 
Surface Oncology Inc   8.25 
Jounce Therapeutics inc   8.24 
Bioatla Inc   8.14 
Recursion Pharmaceuticals Inc   7.67 
Evaxion Biotech A  7.63 
Ikena Oncology Inc   7.59 
Biondvax Pharmaceuticals Ltd   7.50 
Dyadic International Inc  7.18 
C4 Therapeutics Inc   7.06 
Senti Biosciences Inc   6.93 
Ambrx Biopharma Inc   6.92 
Compugen Ltd  6.89 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GAHC's Profile

Stock Price

GAHC's Financials

Business Description

Fundamentals

Charts & Quotes

GAHC's News

Suppliers

GAHC's Competitors

Customers & Markets

Economic Indicators

GAHC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071